UK pharma opposes proposals to base off-label prescribing decisions on cost
This article was originally published in SRA
Executive Summary
A proposal by the UK's General Medical Council to allow doctors to prescribe unlicensed or "off-label" medicines on the basis that they are less expensive than licensed medicines meeting the same clinical need has been criticised by the pharmaceutical industry, which says the practice will put patient safety at risk and undermine the medicines regulatory process1-4.